Antigen-specific T cell balance reveals Why patients with atopic dermatitis fail to achieve immune tolerance

Clin Immunol. 2023 Jul:252:109649. doi: 10.1016/j.clim.2023.109649. Epub 2023 May 18.

Abstract

The number of regulatory T cells (Tregs) and how they behave in the pathogenesis of atopic dermatitis (AD) are still controversial. We identified and quantified Tregs, mite-specific Tregs, and mite-specific effector T cells (Teffs) in patients with AD and healthy controls (HCs). We collected peripheral blood and analyzed the cells using flow cytometry after stimulation with mite antigens. Mite-specific Tregs and mite-specific Teffs were recognized by the expression of CD137 and CD154, respectively. Patients with AD had more Tregs than HCs; however, when focusing on a single antigen, the ratio of mite-specific Tregs/Teffs was lower in patients with AD than in HCs. Furthermore, the mite-specific Teffs in patients with AD were more likely to produce proinflammatory cytokines interleukin (IL)-4 and IL-13. This Teff-dominant imbalance is thought to be the cause of development of atopic status in patients with AD without immune tolerance.

Keywords: Antigen specificity; Atopic dermatitis; CD137; CD154; Mite antigen; Regulatory T cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens
  • Cytokines / metabolism
  • Dermatitis, Atopic*
  • Humans
  • Immune Tolerance
  • T-Lymphocytes, Regulatory

Substances

  • Antigens
  • Cytokines